Endocrine Drugs Explained: From Hydrocortisone to Tirzepatide

Thyroid medications are crucial for patients with hypothyroidism, where the thyroid gland doesn't produce enough hormones.Hypothyroidism presents with symptoms like fatigue, weight gain, cold intolerance, dry skin, and depression - all stemming from slowed metabolism.The primary treatment is levothyroxine, a synthetic version of the thyroid hormone thyroxine or T4.Levothyroxine supplements the body's thyroid hormone levels, which regulate metabolism, energy, and growth in cells throughout the body.Proper dosing of levothyroxine is critical and based on blood tests measuring thyroid-stimulating hormone or TSH levels.As levothyroxine dosage increases, TSH levels decrease in an inverse relationship. The goal is to maintain TSH within the normal range.Sex hormones form another important category of endocrine medications. The three main sex hormones are estrogen, progesterone, and testosterone.These hormones have important clinical applications. Estrogen and progesterone are used in hormone replacement therapy for menopausal symptoms and for contraception.Testosterone replacement therapy is used to treat hypogonadism in men, a condition where the body doesn't produce enough testosterone.Sex hormones work by binding to specific receptors throughout the body.When a hormone binds to its receptor, it triggers a cascade of cellular events, ultimately influencing gene expression in the nucleus.The side effects of hormonal medications vary by hormone type but can include serious complications. These may include cardiovascular events, blood clots, increased cancer risk, liver dysfunction, and mood changes.Due to these potential risks, hormone therapy requires careful patient selection and regular monitoring through blood tests, blood pressure checks, cancer screenings, liver function tests, and regular follow-up visits.Modern diabetes medications have evolved dramatically in recent years, with GLP-1 receptor agonists representing a major breakthrough.GLP-1, or Glucagon-Like Peptide-1, is an incretin hormone naturally produced in the intestine after eating.GLP-1 receptor agonists work by mimicking this hormone and affecting multiple organs in the body.In the pancreas, they stimulate insulin secretion when blood glucose rises, while suppressing glucagon release.They also slow gastric emptying in the stomach and reduce appetite through effects on the central nervous system.Several GLP-1 receptor agonists are now available. The most widely used include semaglutide, marketed as Ozempic for diabetes and Wegovy for weight management, and tirzepatide, marketed as Mounjaro for diabetes and Zepbound for weight management.Tirzepatide represents the newest generation, acting as a dual GIP/GLP-1 receptor agonist with enhanced glycemic control and weight loss effects.GLP-1 receptor agonists offer several important clinical benefits. They provide excellent glycemic control while promoting significant weight loss. Studies have also shown cardiovascular benefits beyond glucose control. And they're conveniently administered as once-weekly injections.However, these medications do have some side effects.The most common side effects are gastrointestinal, including nausea, vomiting, diarrhea, and constipation. Fortunately, these symptoms often improve with continued use and proper dose titration.The indications for GLP-1 receptor agonists have expanded over time. First approved in 2005 for diabetes, they evolved to once-weekly formulations by 2014. In 2021, high-dose formulations received approval for weight management in non-diabetic patients with obesity. The newest dual receptor agonists arrived in 2022 and 2023.Research is exploring even more applications for GLP-1 receptor agonists. These include cardiovascular disease prevention and treatment, management of liver diseases like non-alcoholic steatohepatitis, and potential benefits in neurodegenerative disorders like Alzheimer's and Parkinson's disease.